FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

421166008: Foam (basic dose form)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2006. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2616631014 Foam en Synonym Active Entire term case insensitive SNOMED CT core module
3534585010 Foam (basic dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Foam Is a Basic dose form with semi-solid state of matter false Inferred relationship Existential restriction modifier
Foam Is a Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Foam Has state of matter Liquid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Drug aerosol foam Is a False Foam Inferred relationship Existential restriction modifier
Conventional release cutaneous foam Is a False Foam Inferred relationship Existential restriction modifier
Conventional release vaginal foam Is a False Foam Inferred relationship Existential restriction modifier
Conventional release rectal foam Is a False Foam Inferred relationship Existential restriction modifier
Product containing precisely felbinac 31.7 milligram/1 gram conventional release transdermal foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Product containing precisely nonoxinol 125 milligram/1 gram conventional release vaginal foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Conventional release rectal foam Has basic dose form True Foam Inferred relationship Existential restriction modifier
Conventional release vaginal foam Has basic dose form True Foam Inferred relationship Existential restriction modifier
Conventional release cutaneous foam Has basic dose form True Foam Inferred relationship Existential restriction modifier
Conventional release transdermal foam Has basic dose form True Foam Inferred relationship Existential restriction modifier
Conventional release oropharyngeal foam Has basic dose form True Foam Inferred relationship Existential restriction modifier
Conventional release foam for injection Has basic dose form True Foam Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (CST Pharma Ltd) 14 dose Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (CST Pharma Ltd) Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (DE Pharmaceuticals) Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (DE Pharmaceuticals) 14 dose Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (CST Pharma Ltd) 14 dose Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (CST Pharma Ltd) Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Mesalazine 1g/dose rectal foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 100 milligram/1 milliliter conventional release rectal foam (clinical drug) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Product containing precisely nonoxinol 125 milligram/1 gram conventional release vaginal foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Product containing precisely felbinac 31.7 milligram/1 gram conventional release transdermal foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Product containing precisely ibuprofen 50 milligram/1 gram conventional release cutaneous foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Product containing precisely phenothrin 5 milligram/1 gram conventional release cutaneous foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Prednisolone 20mg rectal foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Hydrocortisone 1% + Pramocaine 1% foam enema Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Betamethasone 0.1% foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (Pharmaram Ltd) 60 gram Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (Pharmaram Ltd) Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (Pilsco Ltd) 60 gram Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (Pilsco Ltd) Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (DE Pharmaceuticals) 60 gram Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (DE Pharmaceuticals) Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Budesonide 2mg foam enema Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Budesonide 2mg foam enema 14 dose Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Bettamousse 0.1% cutaneous foam (Waymade Healthcare Plc) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Bettamousse 0.1% cutaneous foam (Waymade Healthcare Plc) 100 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 100 milligram/1 milliliter conventional release rectal foam (clinical drug) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Product containing precisely felbinac 31.7 milligram/1 gram conventional release transdermal foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Product containing precisely ibuprofen 50 milligram/1 gram conventional release cutaneous foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Product containing precisely phenothrin 5 milligram/1 gram conventional release cutaneous foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Hydrocortisone 1% + Pramocaine 1% foam enema Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Traxam 3.17% foam (Goldshield Healthcare Ltd) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Predfoam 20mg/application enema (Forest Laboratories UK Ltd) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema 14 dose Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Felbinac 3.17% foam 100 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Hydrocortisone 10% foam aerosol enema 14 dose Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Viatris UK Healthcare Ltd) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Hydrocortisone 1% / Pramocaine 1% foam enema 40 dose Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Proctofoam HC foam enema (Meda Pharmaceuticals Limited) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Betamethasone 0.1% foam 100 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Bettamousse 0.1% cutaneous foam (Celltech Pharmaceuticals Ltd) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Phenothrin 0.5% foam 50 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Phenothrin 0.5% foam 150 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Full Marks 0.5% mousse (SSL International Plc) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Nonoxinol-9 12.5% vaginal foam aerosol 20 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Delfen 12.5% contraceptive foam (Janssen-Cilag Ltd) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Asacol 1g/application foam enema (Procter & Gamble Pharmaceuticals UK Ltd) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Salofalk 1g/application foam enema (Dr Falk Pharma UK Ltd) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Ibuprofen 5% foam 75 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Ibuprofen 5% foam 125 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Ibuleve 5% Mousse (Dendron Brands Ltd) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Ibumousse 5% (Dermal Laboratories Ltd) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Clobetasol 500micrograms/g foam 100 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Traxam 3.17% foam (Goldshield Healthcare Ltd) 100 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Predfoam 20mg/application enema (Forest Laboratories UK Ltd) 14 dose Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Colifoam 10% aerosol (Viatris UK Healthcare Ltd) 14 dose Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Proctofoam HC foam enema (Meda Pharmaceuticals Limited) 40 dose Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Bettamousse 0.1% cutaneous foam (Celltech Pharmaceuticals Ltd) 100 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Full Marks 0.5% mousse (SSL International Plc) 50 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Full Marks 0.5% mousse (SSL International Plc) 150 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Delfen 12.5% contraceptive foam (Janssen-Cilag Ltd) 20 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Asacol 1g/application foam enema (Allergan Ltd) 14 actuation Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Salofalk 1g/application foam enema (Dr. Falk Pharma UK Ltd) 14 actuation Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Ibuleve 5% Mousse (Dendron Brands Ltd) 75 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Ibumousse 5% (Dermal Laboratories Ltd) 125 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) 100 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Prednisolone 20mg rectal foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Bettamousse 0.1% cutaneous foam (Sigma Pharmaceuticals Plc) Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Bettamousse 0.1% cutaneous foam (Sigma Pharmaceuticals Plc) 100 gram Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Mesalazine 1g/dose rectal foam Has manufactured dose form False Foam Inferred relationship Existential restriction modifier
Traxam 3.17% foam (Goldshield Healthcare Ltd) Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Felbinac 3.17% foam 100 gram Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Product containing precisely felbinac 31.7 milligram/1 gram conventional release transdermal foam Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Traxam 3.17% foam (Goldshield Healthcare Ltd) 100 gram Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Salofalk 1g/application foam enema (Dr Falk Pharma UK Ltd) Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Mesalazine 1g/application foam enema 14 actuation Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Mesalazine 1g/dose rectal foam Has dispensed dose form False Foam Inferred relationship Existential restriction modifier
Salofalk 1g/application foam enema (Dr. Falk Pharma UK Ltd) 14 actuation Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Asacol 1g/application foam enema (Allergan Ltd) 14 actuation Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Asacol 1g/application foam enema (Procter & Gamble Pharmaceuticals UK Ltd) Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Full Marks 0.5% mousse (SSL International Plc) 150 gram Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Full Marks 0.5% mousse (SSL International Plc) 50 gram Has dispensed dose form True Foam Inferred relationship Existential restriction modifier
Product containing precisely phenothrin 5 milligram/1 gram conventional release cutaneous foam Has dispensed dose form True Foam Inferred relationship Existential restriction modifier

Page 1 of 3 Next End

This concept is not in any reference sets

Back to Start